Advertisement
The American Journal of Cardiology®
Advanced SearchSave search
Roundtable discussion| Volume 108, ISSUE 10, P1417-1425, November 15, 2011

The Editor's Roundtable: Role of Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Stable Coronary Heart Disease

  • Vincent E. Friedewald
    Correspondence
    Corresponding author: Tel: 830-693-2220; fax: 830-798-0194
    Affiliations
    Moderator and Associate Editor, The American Journal of Cardiology, and Research Professor, University of Notre Dame, Notre Dame, Indiana
    Search for articles by this author
  • William E. Boden
    Affiliations
    Clinical Chief, Division of Cardiovascular Medicine, and Professor of Medicine and Preventive Medicine, University at Buffalo, State University of New York School of Medicine and Biomedical Sciences and Public Health, Buffalo, New York
    Search for articles by this author
  • Gregg W. Stone
    Affiliations
    Professor of Medicine, Columbia University, and Director of Cardiovascular Research and Education, Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York
    Search for articles by this author
  • Clyde W. Yancy
    Affiliations
    Medical Director, Baylor Heart and Vascular Institute, Chief, Cardiothoracic Transplantation, Baylor University Medical Center, Dallas, Texas
    Search for articles by this author
  • William C. Roberts
    Affiliations
    Editor-in-Chief, The American Journal of Cardiology and Baylor University Medical Center Proceedings, Executive Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, and Dean, A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System, Dallas, Texas
    Search for articles by this author
DOI:https://doi.org/10.1016/j.amjcard.2011.06.064
The Editor's Roundtable: Role of Percutaneous Coronary Intervention and Drug-Eluting Stents in Patients With Stable Coronary Heart Disease
Previous ArticleComparison of Platelet Reactivity and Clopidogrel Response in Patients ≤75 Years Versus 75 Years Undergoing Percutaneous Coronary Intervention for Non–ST-Segment Elevation Acute Coronary Syndrome
Next ArticleRelation of Physical Activity to Cardiovascular Disease Mortality and the Influence of Cardiometabolic Risk Factors
      This CME activity is supported by an educational grant from Abbott Vascular, Abbott Park, Illinois.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • American Heart Association
        Heart Disease and Stroke Statistics—2009 Update.
        American Heart Association, Dallas, Texas2009
        View in Article
        • Gibbons R.J.
        • Chatterjee K.
        • Daley J.
        • Douglas J.S.
        • Fihn S.D.
        • Gardin J.M.
        • Grunwald M.A.
        • Levy D.
        • Lytle B.W.
        • O'Rourke R.A.
        • Schafer W.P.
        • Williams S.V.
        ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations.
        Circulation. 1999; 99: 2829-2848
        View in Article
        • Cohn P.F.
        • Fox K.M.
        Silent myocardial ischemia.
        Circulation. 2003; 108: 1263
        View in Article
        • Davies R.F.
        • Goldberg A.D.
        • Forman S.
        • Pepine C.J.
        • Knatterud G.L.
        • Geller N.
        • Sopko G.
        • Pratt P.
        • Deanfield J.
        • Conti C.R.
        • ACIP Investigators
        Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up.
        Circulation. 1997; 95: 2037-2043
        View in Article
        • Madsen J.K.
        • Grande P.
        • Saunamäki K.
        • Thayssen P.
        • Kassis E.
        • Eriksen U.
        • Rasmussen K.
        • Haunsø S.
        • Nielsen T.T.
        • Haghfelt T.
        • Fritz-Hansen P.
        • Hjelms E.
        • Paulsen P.K.
        • Alstrup P.
        • Arendrup H.
        • Niebuhr-Jørgensen U.
        • Andersen L.I.
        • DANAMI Study Group
        Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI).
        Circulation. 1997; 96: 748-755
        View in Article
        • Boden W.E.
        • O'Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.M.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini G.B.
        • Weintraub W.S.
        • COURAGE Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        View in Article
        • Erne P.
        • Schoenenberger A.W.
        • Burckhardt D.
        • Zuber M.
        • Kiowski W.
        • Buser P.T.
        • Dubach P.
        • Resink T.J.
        • Pfisterer M.
        Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction.
        JAMA. 2007; 297: 1985-1991
        View in Article
        • Zellweger M.J.
        • Kaiser C.
        • Brunner-La Rocca H.P.
        • Buser P.T.
        • Osswald S.
        • Weiss P.
        • Mueller-Brand J.
        • Pfisterer M.E.
        • BASKET Investigators
        Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
        J Nucl Med. 2008; 49: 550-556
        View in Article
        • Schomig A.
        • Mehilli J.
        • de Waha A.
        • Seyfarth M.
        • Pache J.
        • Kastrati A.
        A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.
        J Am Coll Cardiol. 2008; 52: 894-904
        View in Article
        • Jeremias A.
        • Kaul S.
        • Rosengart T.K.
        • Gruberg L.
        • Brow D.L.
        The impact of revascularization on mortality in patients with nonacute coronary artery disease.
        Am J Med. 2009; 122: 152-161
        View in Article
        • Bhatt D.L.
        • Roe M.T.
        • Peterson E.D.
        • Li Y.
        • Chen A.Y.
        • Harrington R.A.
        • Greenbaum A.B.
        • Berger P.B.
        • Cannon C.P.
        • Cohen O.J.
        • CRUSADE Investigators
        Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.
        JAMA. 2004; 292: 2096-2104
        View in Article
        • Shaw L.J.
        • Berman O.S.
        • Maron O.J.
        • Mancini G.B.J.
        • Hayes S.W.
        • Hartigan P.M.
        • Weintraub W.S.
        • O'Rourke R.A.
        • Dada M.
        • Spertus J.A.
        • Chaitman B.R.
        • Friedman J.
        • Slomka P.
        • Heller G.V.
        • Germano G.
        • Gosselin G.
        • Berger P.
        • Kostuk W.J.
        • Schwartz R.G.
        • Knudtson M.
        • Veledar E.
        • Bates E.R.
        • McCallister B.
        • Teo K.T.
        • Boden W.E.
        • COURAGE Investigators
        Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy.
        Circulation. 2008; 117: 1283-1291
        View in Article
        • Lin G.A.
        • Dudley R.A.
        • Lucas F.L.
        • Malenka O.J.
        • Vittinghoff E.
        • Redberg R.F.
        Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.
        JAMA. 2008; 300: 1765-1773
        View in Article
        • Serruys P.W.
        • Morice M.-C.
        • Kappetein A.P.
        • Colombo A.
        • Holmes D.R.
        • Mack M.J.
        • Stahle E.
        • Feldman T.E.
        • van den Brand M.
        • Bass E.J.
        • Van Dyck N.
        • Leadley K.
        • Dawkins K.D.
        • Mohr F.W.
        • SYNTAX Investigators
        Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
        N Engl J Med. 2009; 360: 961-972
        View in Article
        • Bhatt D.L.
        • Flather M.D.
        • Hacke W.
        • Berger P.B.
        • Black H.R.
        • Boden W.E.
        • Cacoub P.
        • Cohen E.A.
        • Creager M.A.
        • Easton J.D.
        • CHARISMA Investigators
        Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
        J Am Coll Cardiol. 2007; 49: 1982-1988
        View in Article
        • Farkouh M.E.
        • Dangas G.
        • Leon M.B.
        • Smith C.
        • Nesto R.
        • Buse J.B.
        • Cohen O.J.
        • Mahoney E.
        • Sleeper L.
        • King III, S.
        • Domanski M.
        • McKinlay S.
        • Fuster V.
        Design of the Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial.
        Am Heart J. 2008; 155: 215-223
        View in Article
        • Morrow D.A.
        • Scirica B.M.
        • Karwatowska-Prokopczuk E.
        • Murphy S.A.
        • Budaj A.
        • Varshavsky S.
        • Wolff A.A.
        • Skene A.
        • McCabe C.H.
        • Braunwald E.
        • MERLIN-TIMI 36 Trial Investigators
        Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
        JAMA. 2007; 297: 1775-1783
        View in Article
        • Ridker P.M.
        • Danielson E.
        • Fonseca F.A.H.
        • Genest J.
        • Gotto Jr, A.M.
        • Kastelein J.P.
        • Koenig W.
        • Libby P.
        • Lorenzatti A.J.
        • MacFadyen J.G.
        • Nordestgaard B.G.
        • Shepherd J.
        • Willerson J.T.
        • Glynn R.J.
        Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
        N Engl J Med. 2008; 359: 2195-2207
        View in Article
        • Wolfram R.W.
        • Brewer H.B.
        • Xue Z.
        • Sader L.F.
        • Pichard A.D.
        • Kent K.M.
        • Waksman R.
        Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
        Am J Cardiol. 2006; 98: 711-717
        View in Article
        • Cannon C.P.
        • Braunwald E.
        • McCabe C.H.
        • Rader O.J.
        • Rouleau J.L.
        • Belder R.
        • Joyal S.V.
        • Hill K.A.
        • Pfeffer M.A.
        • Skene A.M.
        • Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Investigators
        Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
        N Engl J Med. 2004; 350: 1495-1504
        View in Article
        • Stone G.W.
        • White H.D.
        • Ohman E.M.
        • Bertrand M.E.
        • Lincoff A.M.
        • McLaurin B.T.
        • Cox D.A.
        • Pocock S.J.
        • Ware J.H.
        • Feit F.
        • Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial Investigators
        Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
        Lancet. 2007; 369: 907-919
        View in Article
        • Stone G.W.
        • Midei M.
        • Newman W.
        • Sanz M.
        • Hermiller J.B.
        • Williams J.
        • Farhat N.
        • Mahaffey K.W.
        • Cutlip D.E.
        • Fitzgerald P.L.
        • Sood P.
        • Su X.
        • Lansky A.L.
        • SPIRIT III Investigators
        Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.
        JAMA. 2008; 299: 1903-1913
        View in Article
        • Patei M.R.
        • Dehmer G.C.
        • Hirshfeld L.W.
        • Smith P.K.
        • Spertus L.A.
        ACCF/SCA/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization.
        Circulation. 2009; 119: 1330-1352
        View in Article

      Article Info

      Footnotes

      This article is based on a discussion among the faculty members originally held on March 12, 2009, and updated on October 25, 2010.

      Identification

      DOI: https://doi.org/10.1016/j.amjcard.2011.06.064

      Copyright

      © 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX